Showing results (131-140 of 333) with videos related to
Sort By:
Pageof 34
Mutation Research|June 1, 1991
Activity of aniline in the mouse bone marrow micronucleus assayJ Ashby, D A Vlachos, H TinwellMutagenesis|July 1, 1989
Inactivity of ethyl acrylate in the mouse bone marrow micronucleus assayJ Ashby, C R Richardson, H TinwellMutation Research|May 1, 1994
Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responsesH Tinwell, P A Lefevre, J AshbyMutagenesis|January 1, 1997
Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocolP A Lefevre, H Tinwell, J AshbyBirth Defects Research. Part B, Developmental and Reproductive Toxicology|December 12, 2003
Comparison of prostate gene expression and tissue weight changes as monitors of antiandrogen activity in GNRH-inhibited ratsC Nellemann, P A Lefevre, J AshbyAntimicrobial Agents and Chemotherapy|March 19, 2002
In vitro activities of peptide deformylase inhibitors against gram-positive pathogensR Wise, J M Andrews, J AshbyMutation Research|November 1, 1990
Activity of urethane and N,N-dimethylurethane in the mouse bone-marrow micronucleus assay: equivalence of oral and intraperitoneal routes of exposureJ Ashby, H Tinwell, R D CallanderCarcinogenesis|September 1, 1980
Comparative activity of 4,4'-diaminobiphenyl (benzidine) and its terphenyl analogue, 4,4'-diaminoterphenyl, in two in vitro assays for potential carcinogenicityJ Ashby, J Styles, R D CallanderQuality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 1, 1994
The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?J Ashby, M O'Hanlon, M J BuxtonCancer Letters|November 1, 1983
6-p-Dimethylaminophenylazobenzothiazole: a potent hepatocarcinogen in the ratB M Elliott, M Robinson, J AshbyPageof 34